Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $56.3900 (0.27%) ($56.3900 - $56.4400) on Wed. Feb. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.94% (three month average) | RSI | 46 | Latest Price | $56.3900(0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(62%) IWC(60%) IBUY(58%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -3.97% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-13%) TBT(-7%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.97% (StdDev 7.94%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $47.29(-16.14%) | Resistance Level | $62.41 | 5 Day Moving Average | $57.33(-1.64%) | 10 Day Moving Average | $61.05(-7.63%) | 20 Day Moving Average | $62.41(-9.65%) | To recent high | -38% | To recent low | 103.4% | Market Cap | $3.502b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |